Switching off the interactions between graphene oxide and doxorubicin using Vitamin C: Combining simplicity and efficiency in drug delivery

  • Zhen Liu
  • , Jingquan Liu
  • , Tao Wang
  • , Qiong Li
  • , Paul S. Francis
  • , Colin J. Barrow
  • , Wei Duan
  • , Wenrong Yang

Research output: Contribution to journalArticlepeer-review

Abstract

Well-controlled, low-toxicity and highly efficient delivery systems for anticancer drugs are a key challenge for the development of a new class of nanocarrier systems for cancer chemotherapy. Graphene oxide (GO) has been developed to be a nanocarrier of anti-cancer drugs due to its large surface area and biocompatibility; however, understanding of the interface chemistry is very limited. In this work, we report efficient loading and controlled release of doxorubicin (DOX) using the tunable surface of GO. A deep understanding of the surface chemistry between GO and DOX is achieved using spectroscopies and atomic force microscopy. Hydrogen bonding and π-π stacking are confirmed to be the non-covalent interactions between the drugs and the carriers. As a result, improvement of DOX delivery from the GO surface can be achieved using vitamin C.
Original languageEnglish
Pages (from-to)1251-1259
Number of pages9
JournalJournal of Materials Chemistry B
Volume6
Issue number8
DOIs
Publication statusPublished - Feb 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Switching off the interactions between graphene oxide and doxorubicin using Vitamin C: Combining simplicity and efficiency in drug delivery'. Together they form a unique fingerprint.

Cite this